CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-31
DOI
10.1002/jcp.29353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion
- (2018) Hua Xin et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Effect of electrical stimulation on neural regeneration via the p38-RhoA and ERK1/2-Bcl-2 pathways in spinal cord-injured rats
- (2018) MoonYoung Lee et al. Neural Regeneration Research
- CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells
- (2018) Xiaona Feng et al. BIOMEDICINE & PHARMACOTHERAPY
- Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
- (2017) Sigrun Smola Viruses-Basel
- EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
- (2016) Yuho Hamaoka et al. CELLULAR SIGNALLING
- Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer
- (2016) Shi-liang Gui et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- CXCL3 contributes to CD133+ CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation
- (2016) Lin Zhang et al. Scientific Reports
- Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
- (2015) Yong Bian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CXCL3 is a Potential Target for Breast Cancer Metastasis
- (2014) Amanda See et al. CURRENT CANCER DRUG TARGETS
- Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
- (2014) Naofumi Mukaida et al. MEDIATORS OF INFLAMMATION
- Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis
- (2014) Takamasa Uekita et al. MOLECULAR CANCER RESEARCH
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Mitochondrial signaling in cell death via the Bcl-2 family
- (2010) Brian Leibowitz et al. CANCER BIOLOGY & THERAPY
- The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
- (2010) Christine Bolitho et al. ENDOCRINE-RELATED CANCER
- Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival
- (2010) Dietrich Doll et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1
- (2009) Ira Kogan-Sakin et al. CARCINOGENESIS
- Inflaming metastasis
- (2009) Alberto Mantovani NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started